These results are indirectly supported by clinical observations that both pediatric and adult NASH patients have elevated circulating and hepatic IFN-γ-producing CD4+ T cells (69, 70). The gene discussed is CD4; the disease is metabolic dysfunction-associated steatohepatitis.